Tag: chimeric antigen receptors

Home / chimeric antigen receptors

Categories

CARVYKTI (ciltacabtagene autoleucel), BCMA-Directed CAR-T Therapy, receives U.S. FDA approval for the treatment of adult patients with relapsed or refractory multiple myeloma

March 2022: According to Johnson & Johnson, a therapy developed by the company and its China-based partner Legend Biotech Corp to treat a kind of white blood cell cancer has been approved by the...
chimeric-antigen-receptors

CAR T-Cell therapy saves leukemia patient in China

Feb 2022: A 12-year-old girl from southwest China's Chongqing Municipality was saved by an unconventional therapy instead of chemotherapy or hematopoietic stem cell transplantation. Yi Mengdie has ...
chimeric-antigen-receptors

Scan the code